ARCHIVES

Phase III Kyprolis Trial Fails OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

ODAC Member Critical Of Amgen For Price Incentives.

March 21, 2008

June Panel Meeting Dropped

June 3, 1977

NCI Warns Of Pill’s Potential Tumor Threat

April 2, 1976

NBCC Sees $2.6 billion for Breast Cancer By Year 2000, Begins Voter Registration Drive

May 10, 1996

Cancer Groups Criticize Prescription Drug Bills.

June 27, 2003

FDA Approves HPV Test

April 25, 2003